« Back to Record
Cherny, N. N., Sullivan, R., Dafni, U., Kerst, J. M., Sobrero, A., Zielinski, C. C., de Vries, E., & Piccart-Gebhart, M. (2017). A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). Annals of oncology, 28(11), 2901-2905. doi:10.1093/annonc/mdw258
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/283992



